Quantitative detection of human immunodeficiency virus type 1 (HIV-1) proviral DNA in peripheral blood mononuclear cells by SYBR green real-time PCR technique

Journal of Clinical Virology

Volumn 29, Issue 4, 2004, Pages 282-289

  Gibellini, Davide ^a   Vitone, Francesca ^a   Schiavone, Pasqua ^a   Ponti, Cristina ^b   La Placa, Michele ^a   Re, Maria Carla ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

HIV 1 proviral DNA; Real time PCR; SYBR Green

Indexed keywords

ANTIRETROVIRUS AGENT; GREEN FLUORESCENT PROTEIN; RNA; VIRUS DNA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE MARKER; DNA DETERMINATION; DRUG MONITORING; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL ASSESSMENT; NEWBORN SCREENING; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SEROPREVALENCE; VIRUS DETECTION; VIRUS LOAD;

EID: 1442286420     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(03)00169-0     Document Type: Article

References (42)

1. Albert J., Fenyo E.M. Simple, sensitive, and specific detection of human immunodeficiency virus type 1 in clinical specimens by polymerase chain reaction with nested primers. J. Clin. Microbiol. 28:1990;1560-1564.
2. Aldea C., Alvarez C.P., Folgueira L., Delgado R., Otero J.R. Rapid detection of herpes simplex virus DNA in genital ulcers by real-time PCR using SYBR green I dye as the detection signal. J. Clin. Microbiol. 40:2002;1060-1062.
3. Bagasra O., Seshamma T., Oakes J.W., Pomerantz R.J. High percentages of CD4-positive lymphocytes harbor the HIV-1 provirus in the blood of certain infected individuals. AIDS. 7:1993;1419-1425.
4. Bay S., Wittwer C.T., King T.C., Elelitoba-Johnson K.S.J. Fluorescence melting curve-based analysis for the detection of the bcl-1/JH translocation in mantle cell lymphoma. Lab. Invest. 79:1999;337-345.
5. Bohling SD, Elelitoba-Johnson KSJ. Development of PCR-based assays for the detection of chromosomal translocations using SYBR Green I. In: Meuer S, Wittwer C, Nakagawara K, editors. Rapid cycle real-time PCR: methods and applications. Berlin: Springer-Verlag; 2001. p. 231-9.
6. Brun-Vezinet F., Boucher C., Loveday C.et al. HIV-1 viral load, phenotype, and resistance in a subset of drug-naive participants from the Delta trial. The National Virology Groups. Delta Virology Working Group and Coordinating Committee. Lancet. 350:1997;983-990.
7. Christopherson C., Kidane Y., Conway B., Krowka J., Sheppard H., Kwok S. PCR-based assay to quantify human immunodeficiency virus type 1 DNA in peripheral blood mononuclear cells. J. Clin. Microbiol. 38:2000;630-634.
8. Chun T.W., Stuyver L., Mizell S.B.et al. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc. Natl. Acad. Sci. U.S.A. 94:1997;13193-13207.
9. Chun T.W., Engel D., Berrey M.M., Shea T., Corey L., Fauci A.S. Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection. Proc. Natl. Acad. Sci. U.S.A. 95:1998;8869-8873.
10. Clementi M., Menzo S., Bagnarelli P.et al. Clinical use of quantitative molecular methods in studying human immunodeficiency virus type 1 infection. Clin. Microbiol. Rev. 9:1996;135-147.
11. Comandini U.V., Sonnerborg A., Vahlne A., Yun Z. Quantification of HIV-1 proviral DNA from peripheral blood mononuclear cells using a high throughput four-competitor competitive PCR. J. Virol. Methods. 69:1997;171-180.
12. Coste J., Montes B., Reynes J.et al. Comparative evaluation of three assays for the quantitation of human immunodeficiency virus type 1 RNA in plasma. J. Med. Virol. 50:1996;293-302.
13. Damond F., Descamps D., Farfara I.et al. Quantification of proviral load of human immunodeficiency virus type 2 subtypes A and B using real-time PCR. J. Clin. Microbiol. 39:2001;4264-4268.
14. Desire N., Dehee A., Schneider V.et al. Quantification of human immunodeficiency virus type 1 proviral load by a TaqMan real-time PCR assay. J. Clin. Microbiol. 39:2001;1303-1310.
15. Eschaich S., Ritter J., Rougier P.et al. Relevance of the quantitative detection of HIV proviral sequences in PBMC of infected individuals. AIDS Res. Hum. Retrovir. 8:1992;1833-1837.
16. Espy M.J., Uhl R., Mitchell P.S.et al. Evaluation of LightCycler PCR for implementation of laboratory diagnosis of herpes simplex virus infections. J. Clin. Microbiol. 38:2000;3116-3118.
17. Finzi D., Blankson J., Siliciano J.D.et al. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat. Med. 5:1999;512-517.
18. Folks T.M., Powell D., Lightfoote M.et al. Biological and biochemical characterization of a cloned Leu-3-cell surviving infection with the acquired immune deficiency syndrome retrovirus. J. Exp. Med. 164:1986;280-290.
19. Gratzl S., Moroni C., Hirsch H.H. Quantification of HIV-1 viral RNA and proviral DNA by isotopic competitive PCR. J. Virol. Methods. 66:1997;269-282.
20. Hammer S.M., Squires K.E., Hughes M.D.et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N. Engl. J. Med. 337:1997;725-733.
21. 3. Antivir. Ther. 2:1997;105-111.
22. Karlsen F., Steen H.B., Nesland J.M. SYBR green I DNA staining increases the detection sensitivity of viruses by polymerase chain reaction. J. Virol. Methods. 55:1995;153-156.
23. Kessler C. Non-radioactive labelling and detection of nucleic acid probes. In: Hames BD, Higgins SJ, editors. Gene probes 1: a practical approach. New York, NY: IRL Press; 1995. p. 93-140.
24. Khadir A., Coutlee F., Saint-Antoine P.et al. Clinical evaluation of Amplicor HIV-1 test for detection of HIV-1 proviral DNA in peripheral mononuclear cells. J. AIDS. 9:1995;257-263.
25. Lalli E., Gibellini D., Santi S., Facchini A. In situ hybridization in suspension and flow cytometry as a tool for the study of gene expression. Anal. Biochem. 207:1992;298-303.
26. Lewin S.R., Vesanen M., Kostrikis L.et al. Use of real-time PCR and molecular beacons to detect virus replication in human immunodeficiency virus type 1-infected individuals on prolonged effective antiretroviral therapy. J. Virol. 73:1999;6099-7103.
27. Lin H.J., Haywood M., Hollinger F.B. Application of a commercial kit for detection of PCR products to quantification of human immunodeficiency virus type 1 RNA and proviral DNA. J. Clin. Microbiol. 34:1996;329-333.
28. McDermott J.L., Giri A.A., Martini I., Bono M., Giacomini M., Campelli A.et al. Level of HIV DNA in peripheral blood mononuclear cells correlates with efficacy of antiretroviral therapy. J. Clin. Microbiol. 37:1999;2361-2365.
29. Mellors J.W., Rinaldo C.R. Jr., Gupta P., White R.M., Todd J.A., Kingsley L.A. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science. 272:1996;1167-1170.
30. Morrison T.B., Weis J.J., Wittwer C.T. Quantification of low-copy transcripts by continuous SYBR Green I monitoring during amplification. Biotechniques. 24:1998;954-958.
31. Morrison T.B., Ma Y., Weis J.H., Weis J.J. Rapid and sensitive quantification of Borrelia burgdorferi-infected mouse tissues by continuous fluorescent monitoring of PCR. J. Clin. Microbiol. 37:1999;987-992.
32. Murphy D.G., Gonin P., Fauvel M. Reproducibility and performance of the second-generation branched-DNA assay in routine quantification of human immunodeficiency virus type 1 RNA in plasma. J. Clin. Microbiol. 37:1999;812-814.
33. Perelson A.S., Neuman A.U., Markowitz M., Leonard J.M., Ho D.D. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science. 271:1996;1582-1586.
34. Perfetto SP, McCrary G. Immunophenotyping and assessment of cell function by three-color flow cytometry of peripheral blood lymphocytes. In: Michael N, Kim JH, editors. HIV protocols. Totowa, NJ: Humana Press; 1999. p. 397-407.
35. Poggi C., Profizi N., Djediouane A., Chollet L., Hittinger G., Lafeuillade A. Long-term evaluation of triple nucleoside therapy administered from primary HIV-1 infection. AIDS. 13:1999;1213-1220.
36. Re M.C., Furlini G., Gibellini D.et al. Quantification of human immunodeficiency virus type 1-infected mononuclear cells in peripheral blood of seropositive subjects by newly developed flow cytometry analysis of the product of an in situ PCR assay. J. Clin. Microbiol. 32:1994;2152-2157.
37. Skalka AM, editor. 1999. Advances in virus research. Seminars in virology: retroviral DNA integration, vol. 52. New York, NY: Academic Press.
38. Wong J.K., Hezareh M., Gunthard H.F., Havlir D.V., Ignacio C.C., Spina C.A.et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science. 278:1997a;1291-1295.
39. Wong J.K., Gunthard H.F., Havlir D.V.et al. Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure. Proc. Natl. Acad. Sci. U.S.A. 94:1997b;12574-12579.
40. Yilmaz G. Diagnosis of HIV infection and laboratory monitoring of its therapy. J. Clin. Virol. 21:2001;187-196.
41. Zazzi M., Romano L., Brasini A., Valensin P.E. Nested polymerase chain reaction for detection of Human immunodeficiency virus type 1 DNA in clinical specimens. J. Med. Virol. 38:1992;172-174.
42. Zhao Y., Yu M., Miller J.W., Chen M., Bremer E.G., Kabat W.et al. Quantification of human immunodeficiency virus type 1 proviral DNA by using TaqMan technology. J. Clin. Microbiol. 40:2002;675-678.